Atossa Therapeutics Inc. (ATOS)
NASDAQ: ATOS
· Real-Time Price · USD
0.75
-0.04 (-5.06%)
At close: Aug 19, 2025, 3:59 PM
0.76
1.31%
Pre-market: Aug 20, 2025, 04:00 AM EDT
-5.06% (1D)
| Bid | 0.75 |
| Market Cap | 96.9M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -26.34M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -3.41 |
| Forward PE | -2.93 |
| Analyst | Buy |
| Ask | 0.8 |
| Volume | 728,394 |
| Avg. Volume (20D) | 1,165,201 |
| Open | 0.78 |
| Previous Close | 0.79 |
| Day's Range | 0.75 - 0.79 |
| 52-Week Range | 0.55 - 1.66 |
| Beta | 0.92 |
About ATOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+13.14%
Atossa Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago · accessnewswire.com
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines f...